Who Owns Zyrtec?

Zyrtec was developed in 1987 by UCB Pharma as a cetirizine-based antihistamine medication. The product was introduced to address the growing demand for effective allergy relief without the drowsiness associated with first-generation antihistamines like Benadryl. Cetirizine offered consumers a non-drowsy alternative for treating allergies.

Johnson & Johnson acquired the rights to market Zyrtec and expanded the brand's presence in the allergy relief market. Under Johnson & Johnson's stewardship, Zyrtec became one of the leading non-drowsy antihistamine brands available over-the-counter. The brand's non-drowsy formula made it particularly popular among consumers who needed allergy relief during work or driving.

Throughout the 1990s and 2000s, Zyrtec grew to become one of America's most popular non-drowsy allergy medications, competing directly with Claritin and other second-generation antihistamines. The brand became known for its fast-acting, long-lasting relief without drowsiness. Johnson & Johnson maintained strict quality standards and conducted extensive safety testing on all Zyrtec products.

In recent decades, Zyrtec has continued to innovate with new formulations and delivery methods. The brand has expanded into specialized products for specific allergy types while maintaining its reputation for effective, non-drowsy relief. Zyrtec remains a leading antihistamine brand globally, with products available in virtually every country.